Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?
Beevers
D G
DG
City Hospital, Birmingham.
Sleight
P
P
D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D016022:Case-Control Studies; D002986:Clinical Trials as Topic; D004095:Dihydropyridines / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017202:Myocardial Ischemia / Q000188:drug therapy; D009543:Nifedipine / Q000627:therapeutic use; D012680:Sensitivity and Specificity
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; C038806:1,4-dihydropyridine; D009543:Nifedipine